Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Naseptin Nasal Cream

Active Ingredient:
neomycin sulfate, chlorhexidine dihydrochloride
Company:  
Alliance Pharmaceuticals See contact details
ATC code: 
D06AX
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Safety Alert HCP Med Info
{arrow_left}
{arrow_right}
Naseptin Nasal Cream (neomycin sulphate, chlorhexidine dihydrochloride) has undergone a formulation change, the excipient Arachis oil (peanut oil) has been removed.

  • Both the original formulation containing Arachis oil and the revised formulation without Arachis oil will be in circulation in the supply chain until November 2025.

  • Extra care regarding patient allergy to either peanut or soya must be taken when prescribing and dispensing Naseptin Nasal Cream during this transition period. The prescriber/dispenser must be aware of the allergy status of each patient and ensure the formulation patients receive is appropriate.

  • The labelling on the original formulation packaging contains a peanut oil boxed warning, the new formulation packaging does not.

For further information, please contact the Medical Information department at Alliance Pharmaceuticals Ltd: call +44 (0)1249 466 966 or email [email protected].

Alliance Pharmaceuticals
Company image
Address
Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
WWW
http://www.alliancepharma.co.uk
Telephone
+44 (0)1249 466 966
Fax
+44 (0)1249 466 977
Medical Information e-mail
[email protected]